cemdisiran
Showing 1 - 11 of 11
Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)
Available
- Paroxysmal Nocturnal Hemoglobinuria
- Pozelimab
- Cemdisiran
- (no location specified)
Aug 31, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)
Not yet recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- Pozelimab
- Cemdisiran
- (no location specified)
Feb 22, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial in Leeds (Pozelimab, Cemdisiran)
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- Pozelimab
- Cemdisiran
-
Leeds, United KingdomRegeneron Study Site
Apr 13, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Ravulizumab, Pozelimab, Cemdisiran)
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- Ravulizumab
- +2 more
-
Whittier, California
- +8 more
Nov 29, 2022
IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA Trial in Worldwide (Placebo, Cemdisiran)
Active, not recruiting
- IgA Nephropathy (IgAN)
- +2 more
- Placebo
- Cemdisiran
-
Vancouver, British Columbia, Canada
- +19 more
Jan 13, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Cemdisiran, Eculizumab, Pozelimab)
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- Cemdisiran
- +3 more
-
Whittier, CaliforniaRegeneron Research Facility
Jan 28, 2022
Generalized Myasthenia Gravis Trial in Worldwide (Pozelimab + Cemdisiran, Cemdisiran, Placebo)
Recruiting
- Generalized Myasthenia Gravis
- Pozelimab + Cemdisiran
- +3 more
-
Phoenix, Arizona
- +46 more
Jan 31, 2023
Atypical Hemolytic Uremic Syndrome Trial in Ranica (cemdisiran, Placebos)
Withdrawn
- Atypical Hemolytic Uremic Syndrome
- cemdisiran
- Placebos
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele D
Mar 8, 2021
Atypical Hemolytic Uremic Syndrome Trial in Worldwide (Cemdisiran)
Withdrawn
- Atypical Hemolytic Uremic Syndrome
- Cemdisiran
-
Sarajevo, Bosnia and Herzegovina
- +11 more
Sep 27, 2018